Working... Menu

Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02721979
Recruitment Status : Recruiting
First Posted : March 29, 2016
Last Update Posted : March 14, 2019
Janssen Scientific Affairs, LLC
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2, 2020
  Estimated Study Completion Date : November 2, 2021